Examination of the immunosuppressive effect of Δ9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes

International Immunopharmacology

Volumn 1, Issue 4, 2001, Pages 699-712

  Li, Xinguang ^a   Kaminski, Norbert E ^a   Fischer, Lawrence J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

9 THC; Diabetes; Streptozotocin

Indexed keywords

GAMMA INTERFERON; GLUCOSE; INSULIN; INTERLEUKIN 12; STREPTOZOCIN; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INSULITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ANIMALS; ANTIGENS, CD3; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MICE; RNA, MESSENGER; STREPTOZOCIN; TETRAHYDROCANNABINOL;

EID: 0035102203     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00003-0     Document Type: Article

References (28)

1. Health aspects of cannabis
2. Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression
3. Cannabinoid receptors and immunity
4. Cannabinoid receptors and the cytokine network
5. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2
6. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus
7. Delta-9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: Suppression of post-translational events
8. The role of macrophages in THC-induced alteration of the cytokine network
9. Delta-9-tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
10. Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages
11. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin
12. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets
13. + immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse
14. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction
15. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR
16. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: Implications for the treatment of acute relapses of multiple sclerosis
17. Delta 9-tetrahydrocannabinol: A novel treatment for experimental autoimmune encephalomyelitis
18. Suppression of experimental autoimmune encephalomylitis by cannabinoids
19. Inhibition of adenylate cyclase by delta-9-tetrahydrocannabinol in mouse spleen cells: A potential mechanism for cannabinoid-mediated immunosuppression
20. Insulin-dependent diabetes mellitus: The hypothesis of molecular mimicry between islet cell antigens and microorganisms
21. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM
22. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes
23. Pancreatic islet arachidonic acid turnover and metabolism and insulin release in response to delta-9-tetrahydrocannabinol
24. Streptozotocin-induced diabetes in athymic and conventional BALB/c mice
25. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma
26. Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the Beta-cell binding of T-splenocytes in vitro
27. Toxicity to the insulin-secreting beta cell
28. Multiple low-dose streptozotocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes